27-hydroxycholesterol has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chen, Z; He, T; Jia, H; Li, Y; Lin, J; Lu, L; Shao, W; Tao, B; Yi, C; Zhang, C; Zhang, P; Zhu, W | 1 |
Cai, R; Dai, Y; Jiao, Y; Jin, M; Li, L; Li, Y; Tang, L; Wu, L; Yang, H; Yang, Y; Zhang, Z; Zhou, Y | 1 |
2 other study(ies) available for 27-hydroxycholesterol and Liver Neoplasms
Article | Year |
---|---|
27-Hydroxycholesterol promotes metastasis by SULT2A1-dependent alteration in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Hydroxycholesterols; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Prognosis | 2022 |
27-Hydroxycholesterol is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and metabolic reprogramming.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Multiple; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Hydroxycholesterols; Liver Neoplasms; Membrane Proteins; Mice; Mice, Nude; Oxidation-Reduction; Tumor Microenvironment | 2022 |